Business ❯ Pharmaceutical Industry

Partnerships

Investment Licensing Agreements Research and Development Collaborations Collaboration Agreements Telehealth Mark Cuban BioArctic and Eisai Clinical Trials Biogen Sarepta Therapeutics Innovation Market Competition Abbott Biotechnology Marketing Strategies Strategic Collaborations Funding Commercial Agreements Novo Nordisk Retail Pharmacy Market Access Marketing Practices Market Strategies Market Expansion Retail Partnerships Generic Manufacturing Distribution Agreements Product Development Product Launches

Roche and Nurix Strike $700M Deal to Co‑Develop Oral BTK Degrader Bexobrutideg

Roche’s global scale will accelerate Phase 3 testing to advance the BTK degrader toward wider patient use.

BullFrog AI Strikes Top-5 Pharma Deal To Find Depression Drug Targets

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

FDA Grants Priority Review to Leqembi Autoinjector for Weekly At-Home Starting Dose

Illumina Launches Billion Cell Atlas to Train AI in Drug Discovery

GSK and Ionis Report Phase 3 Success for Hepatitis B Drug, Plan Q1 Filings

AstraZeneca’s LATIFY Phase 3 Finds No Survival Benefit for Ceralasertib Plus Imfinzi in Pre-Treated NSCLC

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Regeneron, Tessera Strike $150 Million Gene-Editing Pact for Alpha‑1 Antitrypsin Deficiency

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November